Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 1,830.56 | 1,655.88 | 1,482.97 | 709.35 |
Total Revenue | 1,830.56 | 1,655.88 | 1,482.97 | 709.35 |
Costof Revenue Total | 1,293.53 | 1,171.31 | 1,105.04 | 462.19 |
Gross Profit | 537.03 | 484.57 | 377.93 | 247.15 |
Selling/ General/ Admin Expenses Total | 103.13 | 241.16 | 179.27 | 117.45 |
Depreciation/ Amortization | 60.39 | 62.93 | 48.06 | 22.83 |
Other Operating Expenses Total | 184.15 | 20.39 | 15.17 | 6.64 |
Total Operating Expense | 1,641.19 | 1,495.79 | 1,342.66 | 609.11 |
Operating Income | 189.37 | 160.09 | 140.31 | 100.24 |
Interest Inc( Exp) Net- Non- Op Total | -191.97 | 5.88 | 68.22 | 61.58 |
Other Net | 7.45 | -16.75 | -11.50 | 0.01 |
Net Income Before Taxes | 177.62 | 144.22 | 136.28 | 106.84 |
Provisionfor Income Taxes | 46.93 | 36.96 | 38.58 | 26.79 |
Net Income After Taxes | 130.69 | 107.26 | 97.70 | 80.05 |
Minority Interest | 0.00 | 0.00 | -0.02 | 0.17 |
Net Income Before Extra Items | 130.69 | 107.26 | 97.67 | 80.22 |
Net Income | 130.69 | 107.26 | 97.67 | 80.22 |
Income Availableto Com Excl Extra Ord | 130.69 | 107.26 | 97.67 | 80.22 |
Income Availableto Com Incl Extra Ord | 130.69 | 107.26 | 97.67 | 80.22 |
Diluted Net Income | 130.69 | 107.26 | 97.67 | 80.22 |
Diluted Weighted Average Shares | 5.53 | 5.54 | 5.52 | 5.19 |
Diluted EPS Excluding Extra Ord Items | 23.62 | 19.38 | 17.70 | 15.47 |
DPS- Common Stock Primary Issue | 0.50 | 0.50 | 0.50 | 0.50 |
Diluted Normalized EPS | 23.62 | 19.34 | 16.99 | 15.40 |
Unusual Expense( Income) | - | 0.00 | -4.88 | - |
Gain( Loss)on Saleof Assets | - | 2.83 | 6.38 | 4.32 |
Rossari Biotech Dividend Rossari Biotech Bonus Rossari Biotech News Rossari Biotech AGM Rossari Biotech Rights Rossari Biotech Splits Rossari Biotech Board Meetings Rossari Biotech Key Metrics Rossari Biotech Shareholdings Rossari Biotech Balance Sheet Rossari Biotech Cashflow Rossari Biotech Q1 Results Rossari Biotech Q2 Results Rossari Biotech Q3 Results Rossari Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks